“iGA represents a fundamental shift in the traditional approach to spine surgery, bringing together the best of our technology, tools and software into one procedurally-integrated platform to address the most correlative element of successful, long-term surgical outcomes — proper alignment,” said NuVasive Chairman and CEO Gregory T. Lucier.
As the third largest player in the $9 billion global spine market, NuVasive will present its products:
• Archon Reconstruction
• VuPoint II
• Cervical ACR
• Osteocel Pro biologic
• XLIF Decade Plate
• X-Core 2
• StruXure for XLIF
More articles on orthopedic devices:
Xtant Medical to participate in NASS meeting: 5 things to know
Nexxt Spine’s manufacturing process aids company growth: 5 key points
NuVasive’s cervical corpectomy cage receives FDA clearance
At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.
